HomeNews

News

First Sufferers Dosed in Section 2 Trial of Ropidoxuridine for Glioblastoma

The primary three sufferers with glioblastoma have begun therapy with ropidoxuridine in a section 2 scientific trial for a brand new mind most...

Prostate Most cancers Questions Answered, From PA Ranges to Therapy Selections

Solutions to widespread questions on prostate most cancers, together with therapy choices, unwanted side effects, and decision-making.A analysis of prostate most cancers may...

Radiation Could Trigger Secondary Most cancers in Some Breast Cancers

Sufferers with breast most cancers who carry TP53 germline variants could develop secondary most cancers related to radiation remedy, in response to research...

Understanding Your Therapy Choices for Superior Prostate

Video content material above is prompted by the next:Are you able to share your strategy to treating superior prostate most cancers?What elements do...

Navigating Publish-Surgical procedure Restoration

Panelists focus on how assessing sufferers' responses to therapy and addressing frequent antagonistic results are important for efficient administration of superior prostate most...

Hot Topics